Item 8.01 Other Events

On April 7, 2009, the Company's Board of Directors (the "Board") approved Mr. Warren L. Bielke, a member of the Board of Directors of the Company (the "Board"), entering into a consulting agreement to provide marketing services to the Company in connection with the launch of the Company's new line of trans-nasal esophagoscopes.

In connection with this arrangement, Mr. Bielke resigned from the Audit Committee effective April 7, 2009, but will remain on the Board. The Board appointed Mr. David W. Anderson, an existing independent board member, to fill the vacancy on the Company's Audit Committee, effective April 7, 2009 and elected him to serve as the Chairman of the Audit Committee. The Company's Board and Audit Committee composition will continue to comply with the corporate governance requirements of Nasdaq and the rules and regulations of the Securities and Exchange Commission.

---